Trial Profile
Effect of rituximab given along with dose-adjusted EPOCH in patients with Burkitt Lymphoma, T-Cell Lymphoma and Large B-Cell Lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Prednisolone; Vincristine
- Indications Burkitt's lymphoma; Diffuse large B cell lymphoma; T-cell lymphoma
- Focus Therapeutic Use
- 29 Apr 2015 New trial record